VJHemOnc

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

VJHemOnc
Aug 4, 2024, 19:11 | Blog
Thrilled to be attending the 1st MPN Workshop of the Carolinas - VJHemOnc
The Video Journal of Hematology & Hematological Oncology shared a post on X: "We are…
Jul 29, 2024, 23:26 | Insight
Luciano Costa provides insight into teclistamab in patients with R/R Multiple Myeloma - VJHemOnc
VJHemOnc shared a post on X: "A recent subgroup analysis focused on the safety and…
Jul 17, 2024, 21:51 | Blog
Beatriz Martin Antonio on the future of cord blood-derived NK cells - VJHemOnc
VJHemOnc (The Video Journal of Hematology and Hematological Oncology) shared a post on X: ''July…
Jul 16, 2024, 23:11 | Blog
The role of TP53 and ctDNA kinetics in patients with R/R DLBCL
VJHemOnc (The Video Journal of Hematology and Hematological Oncology) shared a post on X: ''In…
Jul 14, 2024, 22:08 | Blog
Current strategies for maintaining remission in AML - VJHemOnc
VJHemOnc (The Video Journal of Hematology and Hematological Oncology) shared a post on X: ''What…
Jul 10, 2024, 00:26 | Blog
Myeloma podcast on BCMA-targeting bispeciifc antibodies - VJHemOnc
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) shared on X: "Did you know…
Jul 8, 2024, 10:45 | Blog
Treatment of Chronic Lymphocytic Leukemia and Richter's transformation - VJHemOnc
VJHemOnc shared a post on X: “Do not miss out on our recent session from…
Jun 16, 2024, 14:30 | Blog
Sanam Loghavi and Shahram Kordasti on i4MDS Consortium and the importance of immune monitoring in MDS - VJHemOnc
Sanam Loghavi shared a post by VJHemOnc on X, adding: "Please look out 4 the…
Jun 10, 2024, 16:08 | Blog
It was great to catch up with Mazyar Shadman at ASCO24 - VJHemOnc
VJHemOnc shared a post on X: "It was great to catch up with Mazyar Shadman at…
May 28, 2024, 14:17 | Insight
Paolo Cortesi discusses the value of axi-cel as a second-line treatment in patients with R/R LBCL - VJHemOnc
VJHemOnc shared on X: "Paolo Cortesi (The University of Milano-Bicocca) discusses the value of axi-cel as a…
All: 10 Posts: 1 - 100
Special Coverage